Cargando…
Casein Kinase 1D Encodes a Novel Drug Target in Hedgehog—GLI-Driven Cancers and Tumor-Initiating Cells Resistant to SMO Inhibition
SIMPLE SUMMARY: Uncontrolled activation of hedgehog (HH)—GLI signaling contributes to the development of several human malignancies. Targeted inhibition of the HH—GLI signaling cascade with small-molecule inhibitors can reduce cancer growth, but patient relapse is very common due to the development...
Autores principales: | Peer, Elisabeth, Aichberger, Sophie Karoline, Vilotic, Filip, Gruber, Wolfgang, Parigger, Thomas, Grund-Gröschke, Sandra, Elmer, Dominik Patrick, Rathje, Florian, Ramspacher, Andrea, Zaja, Mirko, Michel, Susanne, Hamm, Svetlana, Aberger, Fritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394935/ https://www.ncbi.nlm.nih.gov/pubmed/34439381 http://dx.doi.org/10.3390/cancers13164227 |
Ejemplares similares
-
DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance
por: Gruber, Wolfgang, et al.
Publicado: (2016) -
Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications
por: Grund-Gröschke, Sandra, et al.
Publicado: (2019) -
Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy
por: Peer, Elisabeth, et al.
Publicado: (2019) -
A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth
por: Lospinoso Severini, Ludovica, et al.
Publicado: (2019) -
From inflammation to gastric cancer – the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases
por: Wessler, Silja, et al.
Publicado: (2017)